|
|
Participating companies
- Alfa Wassermann B.V.
- Amgen Inc
- Amoytop
- Asahi Kasei Medical Co. Ltd
- Baxter Asia Pacific
- Becton Dickinson & Company
- Beijing Tide Pharmaceutical Co. Ltd
- Biologics Consulting Group
- BioPlan Associates, Inc.
- Camber Corporation
- Cancer Institute of the Second Military Medical University
- Emerson Process Management Asia Pacific Pte Ltd
- Forwell Biopharm Co., Ltd.
- GE Healthcare
- Genentech, Inc
- High Tech Business Decisions
- Human Antibodomics
- John Curling Consulting
- Liaoning Cheng Da Biotechnology, Co., Ltd.
- M+W Zander (Shanghai) Co. Ltd
- Millipore China Ltd
- Novozymes China
- PAA Laboratories GmbH
- Prometic Bioscience
- Prometic Biotherapeutics inc.
- Rame-Hart, Inc.
- SAIC Federick, National Center Institute at Federick
- Satorius Biotech
- SciGen Ltd
- Shanghai United Cell Biotechnology Co., Ltd.
- Siemens Ltd China
- Strategic Manufacturing Worldwide, Inc.
- Tasly Jenner Biotech (Tianjin)
- Tianyuan Biopharmaceutical Co. Ltd
- University of Toronto
- Wison (Shanghai) Bioengineering Co. Ltd
- Wison Group Holding Limited
- Zhejiang Tianyuan Bio Pharmaceutical Co. Ltd.
|
|
|
